According to IP Watch:
Pharmaceutical companies are manipulating the intellectual property rights system and are “actively trying to delay the entry of generic medicines onto their markets,” a top EU official said of an EU inquiry into the pharmaceutical sector released Wednesday. As a result, there has been a decline in the number of innovative medicines getting to the market, it says.Also, excellent coverage at IPKat here.
Meanwhile, Canada's Competition Bureau is busy working on the menace of the Nigerian Letter Scam. Hopefully, they are also doing other things in IP - but there's little sign of it, other than holding an invitation only symposium that resulted in a recently published book that I will comment on in due course.